Since the release of our first corporate responsibility report in 2005, Merck has been committed to using the Global Reporting Initiative (GRI) guidelines to report our performance on environmental, social, and governance (ESG) issues.
With the exception of 2009, due to data collection challenges and the harmonization process following the merger with Schering-Plough, Merck has utilized the GRI as well as the Access to Medicines Index (ATMI), the United Nations Global Compact Communication on Progress (UNGC COP), and the UN Millennium Development Goals (MDG) as our overall framework for corporate responsibility reporting. Our 2010 corporate responsibility report once again reflects our commitment to the GRI as well as to the other indices in our first comprehensive report following the merger.
Access to Medicines Index
